# V1 Empirics Check — deepseek/deepseek-v3.2 (Variant B)

**Model:** deepseek/deepseek-v3.2
**Variant:** B
**Date:** 2026-03-27T14:44:31.496721

---

**Referee Report: “The Destigmatization Dividend: Conversion Therapy Bans and Adolescent Mental Health”**

**1. Idea Fidelity**

The paper substantially deviates from the proposed research design outlined in the original Idea Manifest, compromising its ability to deliver on the promised contribution. Key discrepancies include:
*   **Treatment States:** The manifest specified exploiting "24 U.S. states + DC" with staggered adoption. The paper analyzes only 14 treated states appearing in the YRBSS sample. This drastic reduction (from 24 to 14) severely undercuts the promised "massive improvement over [the] single prior study" and the power of the staggered design. The authors must justify this sample attrition and demonstrate results are not sensitive to it.
*   **Identification Strategy:** The manifest's core identification plan was a "Staggered DiD with Callaway-Sant'Anna (2021)" and a "Triple-difference comparing LGB-identified vs. heterosexual youth." The paper's primary estimates rely on a traditional Two-Way Fixed Effects (TWFE) model, which is known to be potentially biased with staggered timing and heterogeneous treatment effects. The Callaway-Sant'Anna estimator is relegated to a single, poorly-explained robustness check that yields null results, undermining the main findings. The triple-difference is mentioned but not properly implemented as a three-way interaction (Ban × LGB × Post); instead, heterogeneity is shown via split samples and a simple Ban × LGB interaction in a cross-sectional 2021-2023 subsample, which lacks the within-state, over-time comparison that strengthens causal claims.
*   **Data and Outcomes:** The paper correctly uses YRBSS data but does not leverage the full 2012-2023 timeline as implied. It starts in 2015, missing the early adoption years for California (2012) and New Jersey (2013) in the pre-period. The analysis of "substance use" and "bullying victimization" from the manifest is absent, though bullying is used as a placebo.

**2. Summary**

This paper investigates the effect of state-level bans on conversion therapy for minors on adolescent mental health. Using YRBSS data from 2015-2023 and a difference-in-differences framework, it finds that bans reduce population-level rates of persistent sadness and suicide planning. It further shows that these effects are concentrated among LGB-identified youth, particularly for suicide attempts. The authors interpret this as evidence of a "destigmatization dividend."

**3. Essential Points**

The following issues must be convincingly addressed for the paper to constitute a reliable causal analysis:

1.  **Reconcile the Treatment Sample:** The paper's credibility hinges on exploiting far more treatment variation than the prior literature. The discrepancy between the 24 banned states in the manifest and the 14 used in the analysis is alarming. The authors must:
    *   List which of the 24 banned states are excluded and explain why (e.g., non-participation in YRBSS, missing outcome data).
    *   Conduct a formal analysis to show that the excluded states are not systematically different from those included on observable dimensions (e.g., political leanings, pre-existing trends in adolescent mental health).
    *   Discuss the implications of this attrition for external validity and statistical power.

2.  **Strengthen Causal Identification Against Policy Endogeneity:** The parallel trends assumption is vulnerable because states that choose to ban conversion therapy are likely on different trajectories for LGBTQ+ acceptance and adolescent mental health. The paper's evidence supporting parallel trends is weak.
    *   **Event Study:** A dynamic event-study graph (coefficients for leads and lags) is essential. The claim that "the event study shows no evidence of pre-trends" is not supported without presenting the graph and conducting a formal test of pre-treatment coefficients.
    *   **Confounding Policies:** The control for "other LGBTQ+ laws" is mentioned but not shown. The authors must include a rigorous analysis of concurrent policies (e.g., anti-discrimination laws, school bathroom bills, gender-affirming care bans) as covariates or in a balancing test. The adoption of a conversion therapy ban is not a random event; it is part of a bundle of progressive social policies.

3.  **Implement a Rigorous Triple-Difference Design:** The current sexual identity analysis is the paper's most compelling element but is poorly identified. The authors must:
    *   Estimate a proper triple-differences (DDD) model using the *full* panel data (2015-2023), interacting `Ban`, `Post`, and `LGB` indicators, with state and year fixed effects. This uses heterosexual youth within the same state and year as a more credible within-state control group, absorbing time-varying state-level confounders.
    *   Acknowledge the limitation that sexual identity data is not available in all waves for all states. The current cross-sectional analysis for 2021-2023 (`LGB` is not time-varying) is vulnerable to state-level selection bias. The DDD model with available data would still be a major improvement.
    *   Discuss the validity of the "placebo" assumption: that any time-varying state shocks affect LGB and heterosexual youth's mental health trends proportionally.

**4. Suggestions**

*   **Data & Sample Construction:**
    *   **Timeline:** Justify the start year of 2015. If earlier YRBSS waves (2011, 2013) are available and contain state identifiers, they should be incorporated to build a longer pre-period for early adopters like CA and NJ, or their exclusion must be rigorously justified.
    *   **Weighting:** Explicitly state how survey weights are used in the regression and robustness checks. The standard error calculation with weights and state-level clustering can be complex; verify the method.
    *   **Sample Table:** Expand Table 1 to show the number of observations and mean outcomes by state and by treatment cohort (year of adoption). This transparency is crucial for assessing the staggered design.

*   **Empirical Analysis:**
    *   **Primary Estimator:** Make the Callaway-Sant'Anna (CS) estimator the primary specification, as originally intended. Present the full set of group-time average treatment effects and the event-study plot from the CS method. Discuss the discrepancy between the TWFE and CS results (Table 4, Panel B) in depth. Is the TWFE estimate biased by negative weighting? The CS null result for persistent sadness is a major red flag.
    *   **Robustness Checks:**
        *   Conduct a **stacked regression** as an alternative to CS, which is often more intuitive and handles staggered adoption well.
        *   Include **state-specific linear time trends** to account for diverging pre-existing trends.
        *   Perform a **falsification test** using pseudo-treatment dates (e.g., 2 or 4 years before the actual ban).
    *   **Mechanism Exploration:** The "destigmatization dividend" is plausible but not tested. Suggest ways to provide supporting evidence:
        *   Use YRBSS items on perceived school safety, teacher support, or community acceptance as intermediate outcomes.
        *   Interact the ban effect with state-level measures of public opinion toward LGBTQ+ individuals (from surveys like the CCES or GSS) to see if effects are larger in initially less supportive states.
        *   Acknowledge more directly that the "direct pipeline" mechanism is likely tiny and that the signaling mechanism, while logical, is inferred rather than proven.

*   **Presentation & Interpretation:**
    *   **Magnitude:** The back-of-the-envelope calculation of "108,000 fewer suicide attempts" is an overextrapolation. The study estimates a *relative* reduction among LGB youth in ban states. Translating this to a national annual figure requires strong assumptions about constant effects and population shares. Tone this down or remove it.
    *   **Heterogeneity:** Explore other dimensions of heterogeneity beyond sexual identity (e.g., by race/ethnicity, gender, grade level). Do bans benefit all LGB youth equally?
    *   **Limitations:** The limitations section is good but should be expanded. Crucially, discuss the potential for **policy anticipation effects** (e.g., advocacy campaigns before a ban's passage may improve mental health) and **spillover effects** (e.g., bans in neighboring states may affect residents who travel for therapy).

*   **Writing & Clarity:**
    *   The abstract's claim of analyzing "22 U.S. states" contradicts the body of the paper (14 states in the sample). Be precise.
    *   Clearly distinguish between the "full sample" analysis (2015-2023, 14 treated states) and the "sexual identity subsample" analysis (2021-2023, cross-sectional). The different identifying assumptions for each should be explicitly stated.
    *   Define "LGB" precisely. Are transgender or questioning youth included? The paper studies conversion therapy bans (which often include gender identity), but the outcome is sexual identity.

**Overall:** The paper addresses a critically important question with a rich dataset and a clever heterogeneity design. However, in its current form, the execution does not meet the high bar for causal inference set by the original proposal. The issues of sample attrition, weak causal identification against confounders, and the improper implementation of the triple-difference design are substantial. If the authors can successfully address the three Essential Points—particularly by reconciling the treatment sample and implementing a robust, heterogeneity-robust estimator with convincing parallel trends evidence—the paper could make a valuable contribution.
